peer reviewedThe objective of this study was to evaluate the discriminative power of different nonmotor signs for early diagnosis of Parkinson's disease (PD). Thirty patients with PD with <or=3 years of disease duration were compared with 30 healthy controls. Six deficit domains (DD) were defined: hyposmia, sleep abnormalities, dysautonomia, visual deficits, executive dysfunction, and depression. Plotting of Receiver operating characteristic (ROC) curves and exact conditional logistic modeling, followed by manual stepwise descending procedure were used to identify a model for nonmotor signs that detects early PD. Patients with PD and controls did not differ in terms of age, gender, and educational level. Several DD discriminated patients wi...
There is sufficient evidence that the pathological process that causes Parkinson's disease begins ye...
Background. Pathological processes in Parkinson’s disease (PD) start long before the first symptoms ...
The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In t...
The objective of this study was to evaluate the discriminative power of different nonmotor signs for...
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. It is a disease with ...
Nonmotor symptoms (NMS) are an important prodromal feature of Parkinson's disease (PD). However, the...
Parkinson’s disease (PD) is a degenerative sub-cortical neurological disorder primarily involving mo...
Early pre-motor symptoms (also frequently termed "non-motor" symptoms) in Parkinson's ...
Background: Early stage (preclinical) detection of Parkinsons disease (PD) remains challenged yet is...
OBJECTIVE: In this study, our purpose is, in the early stage of PD, examining the frequency of occur...
Parkinson's disease (PD) is characterized by typical motor symptoms. However, recent studies show se...
The aim: the identification of patterns of formation and course of non-motor fluctuations in this di...
Background: In clinical trials that recruited patients with early Parkinson's disease (PD), 4-15% of...
The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS) t...
Background/Objectives: Visuospatial problems are common in Parkinson\u27s disease (PD) and likely st...
There is sufficient evidence that the pathological process that causes Parkinson's disease begins ye...
Background. Pathological processes in Parkinson’s disease (PD) start long before the first symptoms ...
The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In t...
The objective of this study was to evaluate the discriminative power of different nonmotor signs for...
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. It is a disease with ...
Nonmotor symptoms (NMS) are an important prodromal feature of Parkinson's disease (PD). However, the...
Parkinson’s disease (PD) is a degenerative sub-cortical neurological disorder primarily involving mo...
Early pre-motor symptoms (also frequently termed "non-motor" symptoms) in Parkinson's ...
Background: Early stage (preclinical) detection of Parkinsons disease (PD) remains challenged yet is...
OBJECTIVE: In this study, our purpose is, in the early stage of PD, examining the frequency of occur...
Parkinson's disease (PD) is characterized by typical motor symptoms. However, recent studies show se...
The aim: the identification of patterns of formation and course of non-motor fluctuations in this di...
Background: In clinical trials that recruited patients with early Parkinson's disease (PD), 4-15% of...
The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS) t...
Background/Objectives: Visuospatial problems are common in Parkinson\u27s disease (PD) and likely st...
There is sufficient evidence that the pathological process that causes Parkinson's disease begins ye...
Background. Pathological processes in Parkinson’s disease (PD) start long before the first symptoms ...
The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In t...